frontal sinus Schneiderian papilloma

Summary

frontal sinus Schneiderian papilloma (MONDO:0003752) is a disease. A subtype of paranasal sinus Schneiderian papilloma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	frontal sinus Schneiderian papilloma
Mondo ID	MONDO:0003752
DOID	DOID:6054
NCIT	C6837
UMLS	C1333645
MedGen	234273
GARD	0023652
Is cancer (heuristic)	no

Also known as: frontal sinus Schneiderian papilloma · Schneiderian papilloma of the frontal sinus

Disease family

This is a subtype of paranasal sinus Schneiderian papilloma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › respiratory system benign neoplasm › paranasal sinus Schneiderian papilloma › frontal sinus Schneiderian papilloma

Related subtypes (3): ethmoid sinus Schneiderian papilloma, sphenoid sinus Schneiderian papilloma, maxillary sinus Schneiderian papilloma

Subtypes (1): frontal sinus inverted papilloma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.